TY - JOUR
T1 - Co-prevalence of Epstein–Barr virus and high risk human papillomaviruses in Syrian women with breast cancer
AU - Al Moustafa, Ala-Eddin
AU - Al-Antary , Noor
AU - Aboulkassim, Tahar
AU - Akil, Nizar
AU - Batist, Gerald
AU - Yasmeen, Amber
PY - 2016/4/15
Y1 - 2016/4/15
N2 - We recently performed 2 studies viewing the presence of Epstein–Barr virus (EBV) and high-risk human papillomaviruses (HPVs) types 16, 18, 31, 33 and 35 in human breast cancer in the Syrian population. Herein, we report that EBV and high-risk HPVs are co-present in breast cancer in Syrian women. Therefore, and based on our previous studies and present data, we reveal that 35 (32%) of 108 cancer samples are positive for both EBV and high-risk HPVs and their co-presence is associated with high grade invasive ductal carcinomas (IDCs) with at least one positive lymph nodes, in comparison with EBV and high-risk HPVs-positive samples, which are low to intermediate grade IDCs, respectively. Future studies are needed to confirm the co-presence and the cooperation effect of these onco-viruses in human breast carcinogenesis and metastasis.
AB - We recently performed 2 studies viewing the presence of Epstein–Barr virus (EBV) and high-risk human papillomaviruses (HPVs) types 16, 18, 31, 33 and 35 in human breast cancer in the Syrian population. Herein, we report that EBV and high-risk HPVs are co-present in breast cancer in Syrian women. Therefore, and based on our previous studies and present data, we reveal that 35 (32%) of 108 cancer samples are positive for both EBV and high-risk HPVs and their co-presence is associated with high grade invasive ductal carcinomas (IDCs) with at least one positive lymph nodes, in comparison with EBV and high-risk HPVs-positive samples, which are low to intermediate grade IDCs, respectively. Future studies are needed to confirm the co-presence and the cooperation effect of these onco-viruses in human breast carcinogenesis and metastasis.
UR - https://www.tandfonline.com/doi/full/10.1080/21645515.2016.1139255
U2 - 10.1080/21645515.2016.1139255
DO - 10.1080/21645515.2016.1139255
M3 - Article
SN - 2164-5515
VL - 12
SP - 1936
EP - 1939
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
IS - 7
ER -